共查询到20条相似文献,搜索用时 31 毫秒
1.
Trendelenburg P 《Naunyn-Schmiedeberg's archives of pharmacology》2006,373(2):101-133
List of Contentspage
This is a translation of the article “Physiologische und pharmakologische Versuche über die Dünndarmperistaltik” originally published in Arch. Exp. Pathol. Pharmakol. 81, 55–129, 1917. .Translated by Lammers WJEP, Lammers-van den Berg AM, Morrison JFB, Petroianu PA, Faculty of Medicine Health Sciences, AI Ain, United Arab Emirates. email: Wlammers@uaeu.ac.ae
相似文献
1. | Research Plan and Method ..................................101 | ||||||||
2. |
Physiological experiments on distension-induced peristalsis guinea pig small intestine .................103
| ||||||||
3. | Considerations on the comparative physiology of peristalsis in hollow organs ..........................111 | ||||||||
4. | Distension peristalsis in small intestines of other mammals ..................................................113 | ||||||||
5. |
Comparative pharmacological investigations of small intestinal peristalsis ..................................113
| ||||||||
6. | Summary of the Results .......................................130 | ||||||||
7. | Translator Notes ...................................................131 | ||||||||
8. | References ............................................................132 |
相似文献
2.
B. Bódis O. Karádi O. M. E. Abdel-Salam R. Faludi L. Nagy Gy. Mózsik 《Inflammopharmacology》1997,5(1):29-41
Aims The aim of the present study was to compare the organoprotective (in vivo) and cytoprotective (in vitro) effects of histamine.
Methods In vivo, gastric mucosal damage was produced by intragastric (ig) administration of 1 ml 96% ethanol (EtOH) in Sprague-Dawley
rats. The animals were sacrificed 1 h after EtOH administration, when the gastric mucosal damage was measured. Histamine was
given subcutaneously (sc) 30 min before administration of EtOH with and without PGI2Na (5 μg/kg sc). Gastric acid secretion was also measured 1 h after pylorus ligation in control (saline-), histamine- and
PGI2-treated animals. The affinity, intrinsic activity curves and the values of pD2 and pA2 were determined in EtOH-treated and in PGI2-treated animals.
For the in-vitro studies, a mixed population of rat gastric mucosal cells was isolated by pronase digestion. Cells were preincubated
for 60 min with histamine (10♪−8-10−6 mol/L) with or without PGI2Na (10−4 mol/L). At the end of this incubation period, cells were treated with 15% EtOH with or without 10−6-103 mol/L indomethacin (IND) for 5 min. Cell viability was tested by trypan blue exclusion test and succinic dehydrogenase activity.
Results
Conclusions
This paper was presented at the Section of IUPHAR GI Pharmacology Symposium on ‘Biochemical pharmacology as an approach to
gastrointestinal disorders (basic science to clinical perspectives)’, October 12-14, 1995, Pécs, Hungary. 相似文献
1. | Histamine (20 mg/kg) stimulated, while PGI2 (5 μg/kg) had no effect on gastric acid secretion in rats; |
2. | Histamine inhibited the development of EtOH-induced gastric mucosal damage (pDI2=4.0, pA2=3.75); |
3. | Histamine stimulated the PGI2-induced gastric cytoprotection in vivo (pDI2=4.7, pA2=3.75); |
4. | There was no measurable acid secretion by our method in isolated cells after incubation with 10−8-10−6 mol/L histamine; |
5. | Histamine preincubation did not prevent the EtOH- or IND-induced cell injury. |
1. | Histamine has a protective effect in a non-acid-dependent model in vivo; |
2. | This organoprotection has a metabolic component; |
3. | The cytoprotective effect of histamine failed in vitro; |
4. | The mechanisms of histamine-induced organo- and cytoprotection seem to be different in rats. |
3.
S. M. Kirpekar Arun R. Wakade J. C. Prat 《Naunyn-Schmiedeberg's archives of pharmacology》1976,294(1):23-29
1. | The effect of tetraethylammonium (TEA) and barium on release of noradrenaline (NA) from the cat spleen by nerve stimulation or potassium was investigated. |
2. | In spleens perfused with normal Krebs solution, the NA output at 5 Hz was barely detectable, and the output at 30 Hz was about 5-fold greater than the output at 5 Hz. |
3. | TEA (1 mM) or barium (2.5 mM) increased NA output at 5 Hz by 5-fold, but did not enhance it at 30 Hz. A maximal effect of TEA was obtained at about 1–3 mM. Enhancement of NA release by TEA was readily reversible. Output of NA induced by high potassium was not affected by TEA or barium. |
4. | The effect of TEA on release was related to the external calcium concentration. Insignificant outputs obtained at 5 Hz in 0.1 and 0.5 mM calcium-Krebs solutions were markedly increased by TEA, and were 2- and 5-fold greater than the control output at 5 Hz in normal Krebs solution containing 2.5 mM calcium. TEA enhanced release at all calcium concentrations up to 5 mM, but maximum output was still obtained at 2.5 mM. |
5. | Increasing the potassium concentrations of normal Krebs solution to 10, 15 and 20 mM depressed NA outputs at 5 Hz by 50, 55 and 75%, respectively. TEA (1 mM) partially antagonized the inhibitory effect of potassium on release, and in zero potassium-Krebs solution it increased output by about 50% over that obtained in normal Krebs solution. |
6. | The ratio of NA outputs at 30 and 5 Hz during perfusion with Krebs solution containing TEA was about 0.6, and it approached the normal value as the calcium concentration of the perfusion medium was reduced. TEA facilitated release even at 30 Hz in low-calcium solutions. |
7. | It is suggested that the enhancement of NA release by TEA and barium is due to the greater influx of calcium ions into the sympathetic nerves during the course of an action potential. |
4.
D. J. P. Wijsman Y. A. Hekster A. Keyser W. O. Renier H. Meinardi 《Pharmacy World & Science》1991,13(4):182-188
In order to study the practicability of rating scales in the regular care of people with epilepsy, indices have been developed and tested on their validity. These indices consist of the Index of Seizures, representing seizure activity, and the Composite Index of Impairment concerning the severity of impairment caused by the seizure type and frequency and the side-effects of anti-epileptic drug treatment. The indices have been applied in a retrospective quantitative evaluation of anti-epileptic drug therapy. The medical records of 250 randomly selected patients registered at an adult out-patient clinic have been reviewed. Their seizures have been classified as generalized tonic-clonic, simple partial and/or complex partial. The distribution of this population according to these indices has been studied, which leads us to the following conclusions:
The indices can be determined rapidly and therefore may become valuable aids for the physician in an out-patient clinic to support a decision whether or not to revise current anti-epileptic drug therapy. 相似文献
| the global indices are valid for clinical application; |
| in 18.6% of the patients studied there was severe impairment and unacceptable seizure control; |
| combined types of seizure are difficult to control; |
| no significant difference is demonstrated between monotherapy and polytherapy regarding the amount of neurotoxicity. |
5.
1. | The release of PGs from the isolated perfused rabbit ear was measured by means of a radioimmunoassay. |
2. | Bradykinin in dose dependent amounts released mainly PGE (presumably PGE1) and in much smaller amounts also PGF. |
3. | Bradykinin released similar amounts of PGE in innervated and chronically denervated ears. |
4. | Indomethacin completely prevented the PGE release by bradykinin. |
5. | ACh showed a much lower efficacy than bradykinin in releasing PGE and PGF. Synthetic substance P was devoid of any PGE releasing action. |
6. | It is concluded that bradykinin increases its own algesic action by a concomitant rapid stimulation of the PGE synthesis, thus providing a mechanism for the facilitation of its own algesic action. |
6.
The gastric mucosa responds to mucosal damaging agents by significantly decreasing acid secretion. However, the inhibition
of nitric oxide (NO) biosynthesis by NG-nitro-L-arginine methyl ester (l-NAME) turned the acid-secretory response in the damaged stomach from the ‘inhibition’ into
‘stimulation’ state. The present study was performed to investigate the mechanism underlying stimulation of acid secretion
in the stomach after damage in the presence of l-NAME. Exposure of the chambered rat stomach to 20 mmol/L taurocholate (TC)
for 30 min decreased acid secretion with concomitant reduction of transmucosal potential difference (PD). Pretreatment with
L-NAME, although it had no effect on basal acid secretion, apparently increased the acid secretion in the stomach after exposure
to TC without any change in the PD response. The acid-stimulatory effect of l -NAME in the damaged stomach was reversed by
the co-administration of L-arginine but not D-arginine. Such acid-secretory responses in the presence of L-NAME were also
inhibited by prior administration of cimetidine, FPL-52694 (a mast cell stabilizer), spantide (a substance P antagonist) or
sensory defunctionalization with capsaicin pretreatment. In contrast, mucosal exposure to TC significantly decreased the number
of mucosal mast cells and increased histamine output in the lumen, and these responses were significantly inhibited by FPL-52794,
spantide or sensory deafferentation. These findings suggest that:
相似文献
1. | Damage in the stomach may activate the acid-stimulatory pathway in addition to the NO-dependent inhibitory pathway, although the latter effect overcomes the former, resulting in a decrease in acid secretion; |
2. | The stimulatory pathway is dependent on histamine which may be released from mucosal mast cells in association with capsaicin-sensitive sensory nerves; and |
3. | l-NAME unmasks the acid-stimulatory response by suppressing the inhibitory pathway. |
7.
Sulphasalazine (SASP) is established as a second-line drug in the treatment of rheumatoid arthritis (RA) and some of the seronegative
spondarthritides. It is not clear whether the parent compound, one of its two main metabolites or a combination is responsible
for its therapeutic effect. Much of the drug’s action is also unknown. Since RA and the seronegative spondarthropathies ail
share substantial immunopathology, the immune effects of SASP and/or its main metabolites may play a major part in its action.
This paper reviews:
相似文献
(1) | the clinical evidence for an immune response and the mechanisms underlying this; |
(2) | the effect of SASP and its main metabolites on lymphocyte numbers and function, and |
(3) | the immunological studies designed to identify the active components of the drug. |
8.
1. | Jejunal loops of anaesthetized rats were filled with buffered isotonic solutions of tritiated water (HTO), urea, antipyrine and salicylic acid at pH 6–8. The venous outflow and the appearence rate of the substances in the intestinal venous blood were determined. Blood pressure was kept constant by adjustable supply of blood from donor rats throughout the experiment. |
2 | The absorption of urea, antipyrine and salicylic acid was, in concentrations from 0.001 to 1.0 mg/ml found to be directly proportional to the intraluminal concentration. |
3. | Theophylline and caffeine (2 mg/ml), when injected into the lumen, increased the blood flow to 188% and 166% of controls. |
4. | The theophylline induced increase in blood flow caused an enhancement in the absorption of antipyrine to 153%, HTO and urea to 135% and salicylic acid to 123% of controls. |
5. | Caffeine influenced the absorption of HTO and salicylic acid similar to theophylline. |
9.
Emory S. Martin 《Journal of pharmacokinetics and pharmacodynamics》1991,19(Z3):59S-77S
The following conclusions may be drawn from this study's results:
相似文献
1. | Apriori estimates of theophylline clearance may be improved by consideration of other patient factors beyond patient weight. By modeling clearance with weight (exponentially) and postnatal age, along with a factor for patients receiving parenteral nutrition, estimates of theophylline clearance may be optimized. |
2. | Gender, gestational age, maternal smoking, birth asphyxia, breastmilk feedings, short-term phenobarbital administration, oral dosing, and outpatient status do not appear to significantly influence theophylline clearance in this study population. |
3. | When estimating a neonate's or young infant's volume of distribution for theophylline, considering the patient's weight alone appears to allow an adequate estimation. |
4. | The interindividual variability of theophylline clearance in neonates and young infants is small relative to that seen in children and adults. |
5. | Residual error variability may be relatively high at low serum theophylline concentrations, but it appears to be modest (<15%) at concentrations above 8 mcg/mL. |
10.
Investigations into the therapeutic properties of various combinations of the bispyridinium salts HS-3 and HS-6 and the cholinolytics atropine and benactyzine against soman poisoning in unanesthetized male beagles were performed. In our investigations we observed that:
相似文献
1. | The most effective protection against soman poisoning was attained if both oximes were applied early i.m. 6 min after intoxication together with the cholinolytics. |
2. | On the basis of clinical symptoms HS-6 proved to have a more intensive therapeutic effect than HS-3 upon early application. |
3. | If HS-3 was applied early after s.c. intoxication with low concentrations of soman (up to 3 LD50), a significant protection or reactivation effect on serum cholinesterase was measured. |
4. | When HS-3 was applied at the beginning of convulsions — generally 28 min after s.c. intoxication — it also raised the rate of surviving animals. |
5. | The maximal blood levels for HS-3 and HS-6 were measured 20–30 min after i.m. injection; the half-life values of HS-3 and HS-6 in plasma were 45–60 min. |
11.
Particle counts were performed on 1,000 intravenous administration sets from ten suppliers on the Swiss market using a HIAC/Royco electronic counter. The following main conclusions may be drawn from the results of this study:
相似文献
| the small particles were the most numerous, regardless of the type of set; |
| the differences in the counts obtained for the different suppliers' sets tended to level off for particles larger than 10m; |
| the drip chamber and latex connector may be two important sources of particles; |
| the particulate contamination from the sets is relatively low compared with the amount of particles contained in the parenteral solutions. |
12.
Jacek Sein Anand Zygmunt Chodorowski Roman P. Korolkiewicz Dorota Klimaszyk Magdalena Łukasik-Głębocka 《Central European Journal of Medicine》2006,1(1):99-102
Background: A 24-year-old female had attempted suicide twice, at the age of 20 and 24, using tamoxifen.
Case report: Subsequent to the first acute intoxication a development of bilateral ovarian cysts was observed. Cysts regressed
spontaneously within 8 weeks. Five weeks after the second suicidal attempt, pregnant patient (15 weeks of gestation) was admitted
to the hospital with vaginal bleeding and suspicion of miscarriage. The autopsy of the fetus did not reveal any gross abnormalities,
whereas the microscopic examination demonstrated numerous foci of necrosis in the placental decidua. Other fetal membranes
as well as the umbilical cord were normal.
Conclusions:
相似文献
1. | Acute intoxication with tamoxifen may be connected with the formation of follicular ovarian cysts. |
2. | During pregnancy, intoxication with tamoxifen, may result in delayed miscarriage. |
13.
E. Eckert M. Henseling A. Gescher U. Trendelenburg 《Naunyn-Schmiedeberg's archives of pharmacology》1976,292(3):219-229
Rabbit aortic strips (nerv--free, reserpinepretreated or normal) whose noradrenaline-metabolizing enzymes were inhibited (by in vitro treatment with 0.5 mM pargyline for 30 min and by the presence of 0.1 mM U-0521) were exposed to 1.18 M labelled (-)- or (+)noradrenaline for 30 min. At the end of the incubation period some strips were used for analysis of radioactivity (i.e., of noradrenaline and its metabolites), while for others the efflux of radioactivity was determined during 250 min of wash out with amine-free solution. An estimate of the original distribution of the amine into the various extraneuronal and neuronal compartments of the tissue was obtained by compartmental analysis of the efflux curves.
相似文献
1. | The mechanisms responsible for the accumulation of radioactivity in extraneuronal and axoplasmic compartments lack stereoselectivity; the rate constants for the efflux of radioactivity from these compartments are the same for (-)- and (+)noradrenaline. |
2. | The accumulation of radioactivity in storage vesicles is stereospecific with preference for the (-)isomer. |
3. | Despite the use of enzyme inhibitors, the late neuronal efflux of radioactivity (i.e., the efflux collected between the 200th and 250th min of wash out) contained a considerable proportion of metabolites of noradrenaline. The metabolism of noradrenaline was stereoselective: while dihydroxyphenylglycol (DOPEG) was the predominant metabolite in the efflux from strips incubated with (-)noradrenaline, a considerable part of the efflux from strips incubated with the (+)isomer consisted of dihydroxymandelic acid and O-methylated and deaminated metabolites (in addition to DOPEG). |
14.
Wang Zhonggao 《Frontiers of Medicine in China》2007,1(1):115-119
Asthma is a disorder of the lungs characterized by increased responsiveness of the airways, as manifested by episodes of wheezing
and increased resistance to expiratory airflow because of varying degrees of smooth muscle contraction, edema of the mucosa,
and mucus in the lumen of the bronchi and bronchioles. The stimuli vary widely and include antigens, infection, air pollutants,
respiratory tract irrtants, exercise, and emotional factors. This condition is completely different from distress breathing
because of laryngotracheal spasm. One of its causes is the gastric content reflux through the pharynx to the larynx because
of gastroesophageal reflux disease (GERD), in addition to the typical human avian flu that may cause immediate suffocation
by laryngospasm owing to acute larygotrachitis. A patient suffered from GERD without esophageal symptoms, which was diagnosed
and treated as bronchial asthma during his five emergency admissions. The admissions were because of episodic attacks of severe
air hunger owing to an extreme throat tightening. The patient was being treated for as long as two years. After the correct
diagnosis was made and treatment of laporascopic fundaplication was performed, the longstanding “bronchial asthma”, after
all, completely disappeared. The concept of “not asthma, but GERD” seems undervalued, unappreciated, even misunderstood among
patients with intractable asthma. Therefore, such a case is reported in detail, similar cases are mentioned briefly as well,
and a mechanism responsible for GERD-originated larryngo-or laryngotracho-spasm is proposed. 相似文献
15.
N. M. Deighton A. D. Brown C. A. Hamilton J. L. Reid 《Naunyn-Schmiedeberg's archives of pharmacology》1988,338(5):517-522
In order to study noradrenaline-induced regulation of alpha- and beta-adrenoceptors, groups of male New Zealand White rabbits (n = 8) were treated with intravenous noradrenaline (0.09 mol/kg × h) or ascorbate (0.1 %) for I0 days via osmotic minipumps implanted in the femoral vein, and the number of cardiac, lung and lymphocyte beta-adrenoceptors as well as renal and platelet alpha2-adrenoceptors were determined.
相似文献
1. | The mean arterial blood pressure, heart rate and catecholamine levels were measured before commencing, and after 24 h and 10 days infusion. Circulating noradrenaline concentrations were elevated approximately 6-fold at 24 h and were sustained at these levels after 10 days administration of noradrenaline. There were no significant alterations in the blood pressure while a significant decrease in the heart rate was observed at 24 h. |
2. | Alpha2-adrenoceptor density was assessed using [3H]-yohimbine. A significant decrease in the number of alpha2-adrenoceptors in the kidney was observed following the 10 days infusion with noradrenaline. This down-regulation was in marked contrast to the lack of alteration in platelet alpha2-adrenoceptor number and the platelet alpha2-adrenoceptor mediated aggregatory response. |
3. | The density of beta-adrenoceptors in lymphocytes, heart and lung were quantified using (–)[125I] iodocyanopindolol (ICYP). The noradrenaline infusions caused significant reductions in beta-adrenoceptor number in the heart and lung (containing predominantly 1-adrenoceptors) but not in lymphocytes (possessing mainly 2-adrenoceptors). The K D-values (pM) for ICYP binding to heart and lung were also significantly decreased in the present studies. |
4. | It is concluded that, in this model, a moderate increase in circulating noradrenaline resulted in substantial decreases in alpha- and beta-adrenoceptor number but in a tissue and/or subtype selective manner. |
16.
M. Göthert E. Kennerknecht G. Thielecke 《Naunyn-Schmiedeberg's archives of pharmacology》1976,292(2):145-152
The actions of anaesthetics (diethyl ether, enflurane, chloroform, methoxyflurane) and alcohols (ethanol, 1-propanol, 1-butanol, 1-pentanol) on the noradrenaline release from (and uptake into) the sympathetic nerve terminals were studied in isolated rabbit hearts perfused with Tyrode solution at constant flow rate. The noradrenaline in the perfusate was assayed spectrofluorimetrically.
The inhibition by alcohols and anaesthetics of the noradrenaline output may be due to hydrophobic interaction of the substances with the nicotinic receptors which undergo conformational change on binding the compound; in this way agonist-receptor interaction may be prevented, thus inhibiting stimulus formation. 相似文献
1. | Ethanol, 1-propanol, 1-butanol and all anaesthetics (at concentrations which decreased by more than 65% the noradrenaline output in response to activation of the nicotinic receptors) did not significantly affect the spontaneous noradrenaline output. Only 1-pentanol (3.75×10–3 M) caused an increase in spontaneous noradrenaline output. |
2. | The uptake of exogenous noradrenaline from the perfusion fluid into the sympathetic nerve terminals was not influenced by the anaesthetics and alcohols (at concentrations which decreased by more than 65% the noradrenaline output evoked by stimulation of the nicotinic receptors). |
3. | All anaesthetics and alcohols caused a concentration-dependent inhibition of the noradrenaline release in response to activation of the nicotinic receptors on the nerve terminals by 1,1-dimethyl-4-phenylpiperazine or acetylcholine in the presence of atropine. The concentrations of the compounds which decreased the noradrenaline output by 50% were as follows: diethyl ether: 5.1×10–3 M; enflurane: 2.9 ×10–4 M; chloroform: 2.6×10–4 M; methoxyflurane: 3.8×10–5 M; ethanol: 1.5×10–1 M; 1-propanol: 1.9×10–2 M; 1-butanol: 6.0×10–3 M; 1-pentanol: 1.2×10–3 M. |
4. | The inhibition by the anaesthetics and alcohols of the noradrenaline release evoked by stimulation of the nicotinic receptors was proportional to the membrane/buffer partition coefficients of these compounds (r=0.99). |
17.
T. Sharp R. McQuade S. Bramwell S. Hjorth 《Naunyn-Schmiedeberg's archives of pharmacology》1993,348(4):339-346
1. | Electrophysiological measurements of 5-HT neuronal activity report that repeated administration of 5-HT1A receptor agonists leads to desensitization of the 5-HT1A autoreceptor but this has not yet been detected in measurements of brain 5-HT synthesis or metabolism. Here we have determined the effect of repeated administration of 5-HT1A receptor agonists on brain 5-HT release using microdialysis. |
2. | Acute administration of the 5-HT1A receptor agonists buspirone (0.1–5 mg/kg s.c.) and ipsapirone (0.03–3 mg/kg s.c.) caused a dose-dependent decrease in 5-HT output in ventral hippocampus of the chloral hydrate anaesthetized rat. |
3. | The 5-HT response to buspirone (0.1 and 0.5 mg/kg s.c.) and ipsapirone (0.3 mg/kg s.c.) was significantly inhibited by pre-treatment with the 5-HT1/-adrenoceptor antagonist pindolol (8–16 mg/kg s.c.). The 5-HT response to buspirone (0.1 mg/kg s.c.) and ipsapirone (0.3 mg/kg s.c.) was not blocked by pretreatment with a combination of the 1 and 2-adrenoceptor antagonists metoprolol and ICI 118,551 (4 mg/kg s.c.). |
4. | The effect of an acute challenge of buspirone (0.5 mg/kg s.c.) on 5-HT output in ventral hippocampus was not attenuated in rats treated twice daily for 14 days with 0.5 or 5 mg/kg s.c. buspirone compared to saline-injected controls. Similarly, the decrease in 5-HT induced by an acute challenge of ipsapirone (0.5 mg/kg s.c.) was not attenuated in rats treated twice daily for 14 days with 5 mg/kg s.c. ipsapirone. |
5. | In further experiments it was shown that the decrease in 5-HT induced in both ventral hippocampus and striatum by an acute challenge of the selective 5-HT1A receptor agonist 8-OH-DPAT (0.025 mg/kg s.c.), was not attenuated in rats treated twice daily for 14 days with 1 mg/kg s.c. 8-OH-DPAT. |
6. | Basal levels of 5-HT in hippocampal and striatal microdialysates of animals treated repeatedly with the 5-HT1A receptor agonists were not consistently altered relative to treatment controls. |
7. | In agreement with earlier studies measuring regional brain 5-HT synthesis and metabolism, the present microdialysis measurements of 5-HT release indicate that the inhibitory effect of 5-HT1A receptor agonists on presynaptic 5-HT function is maintained in rats treated repeatedly with the same drugs. |
18.
Rupal K. Parbhoo Karen Wetz Marva Tschampel Vincent Pompili Elena Schenko Lou Mavko Danielle Blais 《Hospital pharmacy》2014,49(7):628-633
Background:
Transradial access has gained popularity over transfemoral access for cardiac catheterization, because of the decreased risk of bleeding, time to ambulation, and length of stay leading to improved patient satisfaction. One disadvantage of the radial artery approach is vasospasm, which can be prevented with the administration of verapamil and nitroglycerin in a pre- and postradial cocktail. Unfortunately, there have been manufacturer shortages for both of these medications.Methods:
The utilization of radial artery cocktails and other nitroglycerin compounding practices were evaluated in response to cost containment and waste reduction initiatives and to medication shortages.Results:
A modified process for supplying verapamil and nitroglycerin for the transradial approach via separate syringes enabled physicians to have quick access to the medications and to customize the cocktail based on the patient’s needs. This process also decreased costs and minimized wastage. The change in practice decreased waste from 44% for preradial cocktail syringes and 66% for postradial cocktail syringes to 8.7%.Discussion:
This process for supplying the medications necessary to perform a radial artery catheterization and intracoronary nitroglycerin has allowed for conservation of commercial product supply.Key Words: verapamil, cardiac catheterization, drug shortage, nitroglycerin, radial artery spasm, stability, transradialAt The Ohio State University Wexner Medical Center (OSUWMC), 4,000 diagnostic catheterizations and 1,500 percutaneous coronary interventions (PCI) are performed annually. Until September 2010, the transfemoral approach accounted for more than 80% of the access sites used for patients undergoing cardiac catheterization procedures. The transradial approach has gained popularity as a way to decrease the number of post-PCI bleeding complications, access site hematomas, and transfusions as well as to decrease the time to ambulation and length of stay.1–4In comparison to the femoral artery, the radial artery is significantly smaller, which predisposes the vessel to vasospasm. One of the most frequent complications of patients undergoing the transradial approach is radial artery spasm; this can cause discomfort for the patient during the procedure and can require that the procedure be stopped or the access site changed. There is no standard definition for radial artery spasm and there are differences in techniques used to perform the procedure, but the incidence of vasospasm is estimated to be between 2% and 51.3%.1–4 Factors other than radial artery spasm can lead to the procedure being stopped or the access site being changed, so the incidence attributable to radial artery spasm alone is not well-established.Intra-arterial administration of vasodilating agents with differing mechanisms of action (ie, verapamil and nitroglycerin) prior to inserting the sheath has been shown to reduce the incidence and severity of radial artery spasm.3,4 Verapamil works by inhibiting calcium influx and contractility of smooth muscles through selective blockade of the L-type voltage-gated calcium channels; nitroglycerin works by releasing nitric oxide, raising cGMP levels, and reducing the calcium concentration to cause relaxation in the smooth muscle. In addition to vasodilating agents, heparin may be used in the preradial cocktail to prevent thrombus formation that may lead to radial artery occlusion when the wire is inserted.Up to 2012 at OSUWMC, the interventional cardiologists could administer a preradial cocktail containing nitroglycerin 200 mcg, verapamil 2.5 mg, and heparin 2,500 units and a postradial cocktail containing nitroglycerin 200 mcg and verapamil 2.5 mg (see 3 Both syringes were diluted with normal saline to a total volume of 10 mL; they had an arbitrary refrigerated 24-hour default expiration date due to the lack of data showing detrimental degradation within this time period or supportive data extending the storage time. This expiration dating falls within the sterility dating as established by the US Pharmacopeia (USP).5 For predrawn syringes, the beyond-use dating for a medium risk level would permit 30 hours at room temperature or 9 days refrigerated without additional sterility testing.Table 1.
Baseline recipe for pre- and postradial cocktails3–4Preradial cocktail: combined in 1 syringe | ||
Ingredients: | Commercial product: | Final syringe contents: |
Heparin | 5,000 units/mL, 1 mL vial | 2,500 units (0.5 mL) |
Nitroglycerin | 5 mg/mL, 10 mL vial | 0.2 mg (0.04 mL) |
Verapamil | 2.5 mg/mL, 2 mL vial | 2.5 mg (1 mL) |
0.9% sodium chloride | QS to 10 mL | |
Postradial cocktail: combined in 1 syringe | ||
Ingredients: | Commercial product: | Final syringe contents: |
Nitroglycerin | 5 mg/mL, 10 mL vial | 0.2 mg (0.04 mL) |
Verapamil | 2.5 mg/mL, 2 mL vial | 2.5 mg (1 mL) |
0.9% sodium chloride | QS to 10 mL | |
Expiration dating | 24 hours refrigerated |
19.
Kristen Bova Campbell Teresa A. Cicci Alyssa K. Vora Lindsey D. Burgess 《Hospital pharmacy》2015,50(10):859-867
Colchicine is one of the oldest medications still in use today and is commonly used for the treatment of gout and familial Mediterranean fever. Its anti-inflammatory properties have raised the question of its utility in managing several cardiovascular diseases, including postoperative atrial fibrillation and pericarditis. This article will review the evidence for colchicine in these conditions and provide recommendations for use.Colchicine is one of the oldest known drugs still prescribed today. It is US Food and Drug Administration (FDA)–approved for the treat-ment of familial Mediterranean fever and acute gout and for prophylaxis against gouty arthritis.1 Colchicine exhibits both antiproliferative and anti-inflammatory actions, primarily via inhibition of microtubule self-assembly through the formation of tubulin-colchicine complexes. This action inhibits the movement of intercellular granules and the secretion of various inflammatory substances. Colchicine has also been found to impair neutrophil adhesion to vascular endothelium. Colchicine shows a preferential concentration for leukocytes, thus decreasing leukocyte motility and blunting the inflammatory response. Peak concentrations in leukocytes may be more than 10 times the peak concentration in plasma; therefore, a therapeutic effect can be seen at relatively low oral doses.2In recent years, colchicine has been evaluated in the management of a number of cardiovascular diseases, most notably the treatment of acute and recurrent pericarditis and prevention of postoperative atrial fibrillation (POAF). In this article, we review the current evidence for colchicine’s role in the treatment of cardiovascular disease and provide recommendations for use. All trials discussed are summarized in Trial (year) N Patient population Intervention Primary endpoint(s) Primary result(s) (colchicine vs placebo) Adverse effects (colchicine vs placebo) PPS and POAF COPPS (2010)8 360 Adults undergoing cardiac surgery without baseline liver, renal, or GI disease Colchicine 1 mg bid on POD 3, followed by 0.5 mg bida x 1 month vs placebo Incidence of PPS at 12 months 8.9% vs 21.1%; P = .002 (NNT = 9) 8.9% vs 5%; P = .212 COPPS AF Substudy (2011)4 336 COPPS patients in sinus rhythm at randomization (POD 3) Colchicine 1 mg bid on POD 3, followed by 0.5 mg bida x 1 month vs placebo Incidence of POAF at 1 month 12.0% vs 22.0%; P = .021 (NNT = 11) 9.5% vs 4.8%; P = .137 COPPS-2 (2014)12 360 Adults undergoing cardiac surgery in sinus rhythm at enrollment Colchicine 0.5 mg bida x 1 month starting 48–72 h before surgery vs placebo PPS within 3 months 19.4% vs 29.4%; 95% CI, 1.1–18.7 (NNT = 10) 20.0% vs 11.7%; 95% CI, 0.76–15.9 (NNH = 12) POAFb 33.9% vs 41.7%; 95% CI, -2.2 to 17.6 (NS) POAF on-treatment analysisb 27.0% vs 41.2%; 95% CI, 3.3–24.7 (NNT = 7)
Acute pericarditis COPE (2005)14 120 Adults with first episode of acute pericarditis and no C/I to colchicine therapy Conventional therapyc plus colchicine 2 mg on day 1, then 1 mg daily x 3 monthsa vs placebo Incidence of recurrent pericarditis 11.7% vs 33.3%; P = .009 (NNT = 5) 8.3% vs 6.7%; P = NS ICAP (2013)15 240 Adults with first episode of acute pericarditis and no C/I to colchicine therapy Conventional therapyd plus colchicine 2 mg on day 1, then 1 mg daily x 3 monthsa vs placebo Incidence of incessant or recurrent pericarditis 16.7% vs 37.5%; P < .001 (NNT = 4) 11.7% vs 10.0%; P = .84
Recurrent pericarditis CORE (2005)21 84 Adults with first episode of recurrent pericarditis Conventional therapyc plus colchicine 2 mg on day 1, then 1 mg daily x 6 monthsa vs placebo Incidence of recurrent pericarditis at 18 months 24.0% vs 50.6%; 95% CI, 2.5–7.1; P = .02 (NNT = 4) 7.1% vs 14.3%; P = .48 CORP (2011)22 120 Adults with first episode of recurrent pericarditis Conventional therapyd plus colchicine 2 mg on day 1, then 1 mg daily x 6 monthsa vs placebo Incidence of recurrent pericarditis at 18 months 24.0% vs 55.0%; 95 CI, 0.13–0.46; P < .001 (NNT=4) 6.7% vs 6.7%; P > .99 CORP-2 (2014)23 240 Adults with ≥2 prior pericarditis recurrences Conventional therapye plus colchicine 0.5 mg bida x 6 months vs placebo Incidence of recurrent pericarditis at 18 months 21.6% vs 42.5%; 95% CI, 0.24–0.65; P = .0009 (NNT = 5) 11.7% vs 8.3%; P = .519